Kim, D.H.; Kim, E.M.; Lee, J.S.; Kim, M.N.; Kim, B.K.; Kim, S.U.; Park, J.Y.; Choi, G.H.; Ahn, S.H.; Lee, H.W.;
et al. Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma. Cancers 2025, 17, 566.
https://doi.org/10.3390/cancers17040566
AMA Style
Kim DH, Kim EM, Lee JS, Kim MN, Kim BK, Kim SU, Park JY, Choi GH, Ahn SH, Lee HW,
et al. Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma. Cancers. 2025; 17(4):566.
https://doi.org/10.3390/cancers17040566
Chicago/Turabian Style
Kim, Dong Hyun, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee,
and et al. 2025. "Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma" Cancers 17, no. 4: 566.
https://doi.org/10.3390/cancers17040566
APA Style
Kim, D. H., Kim, E. M., Lee, J. S., Kim, M. N., Kim, B. K., Kim, S. U., Park, J. Y., Choi, G. H., Ahn, S. H., Lee, H. W., & Kim, D. Y.
(2025). Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma. Cancers, 17(4), 566.
https://doi.org/10.3390/cancers17040566